ReviewCureus2025
Genetics and Phenotypes of Late-Onset Neurodegeneration in Neurodevelopmental Disorders.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of fatigue and other non-motor and motor symptoms in Parkinson's disease.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
- NOTCH3 Mutations in CADASIL: a multicellular perspective on neurodegeneration.Cell communication and signaling : CCS · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Late-onset neurodegenerative diseases may originate from subtle vulnerabilities established during early development, yet the specific mechanisms linking early-life factors to later pathology remain poorly understood. Emerging evidence suggests that prenatal and postnatal influences, including genetic predispositions, maternal health, and environmental exposures, shape neural circuits in ways that may predispose individuals to neurodegeneration. Subclinical abnormalities in synaptic pruning, neurogenesis, and immune regulation are increasingly recognized as latent risk factors, but their precise contribution to disease onset has not been clearly defined. Advances in biomarker discovery, particularly in proteomic, genetic, and imaging domains, offer promising opportunities to detect such vulnerabilities before clinical symptoms arise. Despite these insights, the field lacks longitudinal and mechanistic studies that connect early developmental disruptions to specific neurodegenerative outcomes. Addressing this gap will require integrative research that combines experimental models with life-course studies to clarify causal pathways. By identifying concrete mechanistic links, future work may inform more targeted preventive strategies, rather than broadly proposing reductions in global disease burden.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.